2-FLUORO-1-(2-FLUORO-PHENYL)-ETHANONE, 95.0%, 25g

((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate, 97%, 1g

4,5-Dichloro-3-nitropyridin-2-amine, 95.0%, 5g

(S)-2-Amino-2-(2-bromo-4-fluorophenyl)acetic acid hydrochloride, 98%, 100mg

(2E)-3-(2H-1,3-benzodioxol-5-yl)-1-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 2g

13-(Benzyloxy)-13-oxotridecanoic acid, 95%, 100mg

(R)-5-METHYLCHROMAN-4-AMINE HCL, 95.0%, 1g

(S)-2-((S)-3-AMINO-3-CARBOXYPROPANAMIDO)SUCCINIC ACID, 95%, 50mg

N,N-Dimethyl-1-(5-methyl-1H-indol-3-yl)methanamine, 95.0%, 1g

Thalidomide-O-amido-PEG3-C2-NH2 (TFA), 100mg

4-Methoxynicotinic acid, 95.0%, 1g

(3aS,4S,6aR)-5-fluoro-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, 98%, 50mg

3-Bromo-4-methoxybenzyl alcohol, 98.0%, 5g